The court's decision that AI cannot be an inventor under the Patents Act 1977 presents a unique set of challenges for pharmaceutical companies heavily invested in AI-driven innovation. Similarly ...

Now it’s time for more efficient AIs to take over. After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes. The company is making a foray into ...

Alibaba Group Holding Ltd. unveiled a new version of its AI assistant mobile app that incorporates its latest in-house model, ...